应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ACHV Achieve Life Sciences, Inc.
盘前交易 05-15 08:52:17 EDT
5.01
+0.20
+4.16%
盘前
5.10
+0.09
+1.80%
08:45 EDT
最高
5.08
最低
4.84
成交量
20.86万
今开
4.84
昨收
4.81
日振幅
4.99%
总市值
1.72亿
流通市值
1.63亿
总股本
3,425万
成交额
103.82万
换手率
0.64%
流通股本
3,249万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Achieve Life Sciences, Inc.盘中异动 下午盘快速上涨5.21%
自选股智能写手 · 05-14 03:28
Achieve Life Sciences, Inc.盘中异动 下午盘快速上涨5.21%
奥本海默:维持Achieve Life Sciences(ACHV.US)评级,由优于大市调整至优于大市评级, 目标价由18.00美元调整至11.00美元。
智通财经 · 05-13 20:36
奥本海默:维持Achieve Life Sciences(ACHV.US)评级,由优于大市调整至优于大市评级, 目标价由18.00美元调整至11.00美元。
Achieve Life Sciences Inc 预计每股亏损 24 美分 - 财报前瞻
Reuters · 05-08
Achieve Life Sciences Inc 预计每股亏损 24 美分 - 财报前瞻
健康巡讲:Editas基因编辑疗法让遗传性失明患者重见光明
Reuters · 05-08
健康巡讲:Editas基因编辑疗法让遗传性失明患者重见光明
Achieve Life Sciences, Inc.盘中异动 股价大涨5.92%
自选股智能写手 · 05-01
Achieve Life Sciences, Inc.盘中异动 股价大涨5.92%
Achieve Life Sciences(ACHV.US)获JonesTrading首次覆盖,给予买入评级, 目标价20.00美元。
智通财经 · 04-17
Achieve Life Sciences(ACHV.US)获JonesTrading首次覆盖,给予买入评级, 目标价20.00美元。
美国研究综述-3M、J&J、Nuvalent
Reuters · 04-17
美国研究综述-3M、J&J、Nuvalent
加载更多
公司概况
公司名称:
Achieve Life Sciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Achieve Life Sciences, Inc.成立于1991年10月,OncoGenex技术成立于2000年5月。 公司是一家临床阶段的制药公司,致力于全球的金雀花碱的戒烟开发和商业化。 他们的重点是解决全球吸烟健康流行。 Cytisine是已建立的为期25天的戒烟治疗,已在中东欧地区由Sopharma AD在商标名称TabexTM下批准并销售了20多年。 据估计,超过2000万人使用金雀花碱来帮助治疗尼古丁成瘾,其中包括2000多名在欧洲和新西兰进行的研究者进行的3期临床试验的患者。 这两项试验分别于2011年9月和2014年12月在新英格兰医学杂志上发表。
发行价格:
--
{"stockData":{"symbol":"ACHV","market":"US","secType":"STK","nameCN":"Achieve Life Sciences, Inc.","latestPrice":5.01,"timestamp":1715716800000,"preClose":4.81,"halted":0,"volume":208586,"hourTrading":{"tag":"盘前","latestPrice":5.1,"preClose":5.01,"latestTime":"08:45 EDT","volume":115,"amount":582.1500444999999,"timestamp":1715777113014},"delay":0,"floatShares":32490592,"shares":34251911,"eps":-1.264093,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.2,"latestTime":"05-15 08:52:17 EDT","open":4.84,"high":5.08,"low":4.84,"amount":1038231.9340876,"amplitude":0.049896,"askPrice":5.5,"askSize":50,"bidPrice":5.03,"bidSize":145,"shortable":3,"etf":0,"ttmEps":-1.264093,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715779800000},"adr":0,"adjPreClose":5.01,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":5.1,"preClose":5.01,"latestTime":"08:45 EDT","volume":115,"amount":582.1500444999999,"timestamp":1715777113014},"postHourTrading":{"tag":"盘后","latestPrice":5.01,"preClose":5.01,"latestTime":"18:58 EDT","volume":10,"amount":50.3,"timestamp":1715727480199},"volumeRatio":1.8291690459660683},"requestUrl":"/m/hq/s/ACHV","defaultTab":"news","newsList":[{"id":"2435304197","title":"Achieve Life Sciences, Inc.盘中异动 下午盘快速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435304197","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435304197?lang=zh_cn&edition=full","pubTime":"2024-05-14 03:28","pubTimestamp":1715628531,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日03时28分,Achieve Life Sciences, Inc.股票出现波动,股价快速上涨5.21%。Achieve Life Sciences, Inc.股票所在的生物技术行业中,整体涨幅为1.23%。Achieve Life Sciences, Inc.公司简介:Achieve Life Sciences Inc 是一家专业制药公司,致力于推进金雀花碱作为广泛使用的治疗选择,帮助人们对抗尼古丁成瘾。Achieve 的重点是通过金雀花碱的开发和商业化来解决全球吸烟健康流行病。该信息摘要如下:奥本海默:维持Achieve Life Sciences评级,由优于大市调整至优于大市评级, 目标价由18.00美元调整至11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140328517a599fdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140328517a599fdb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435551327","title":"奥本海默:维持Achieve Life Sciences(ACHV.US)评级,由优于大市调整至优于大市评级, 目标价由18.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435551327","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435551327?lang=zh_cn&edition=full","pubTime":"2024-05-13 20:36","pubTimestamp":1715603817,"startTime":"0","endTime":"0","summary":"奥本海默:维持Achieve Life Sciences(ACHV.US)评级,由优于大市调整至优于大市评级, 目标价由18.00美元调整至11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513203657876221a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513203657876221a8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433986763","title":"Achieve Life Sciences Inc 预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433986763","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433986763?lang=zh_cn&edition=full","pubTime":"2024-05-08 09:18","pubTimestamp":1715131120,"startTime":"0","endTime":"0","summary":" * Achieve Life Sciences Inc 将于5月9日公布截至2024年3月31日的财报,预计季度收入将保持不变。* * LSEG分析师对Achieve Life Sciences Inc的平均预期是每股亏损24美分。* 目前,分析师对该公司股票的平均评级为 \"买入\",建议分类为 7 个 \"强烈买入 \"或 \"买入\",没有 \"持有\",也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Achieve Life Sciences Inc 的 12 个月目标价中位数为 19.00 美元,高于其最新收盘价 4.73 美元。5月8日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433035739","title":"健康巡讲:Editas基因编辑疗法让遗传性失明患者重见光明","url":"https://stock-news.laohu8.com/highlight/detail?id=2433035739","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433035739?lang=zh_cn&edition=full","pubTime":"2024-05-08 03:24","pubTimestamp":1715109843,"startTime":"0","endTime":"0","summary":"基因编辑恢复遗传性失明患者的视力研究人员周二在西雅图举行的视力与眼科研究协会会议上报告说,Editas Medicine 公司的一种基因编辑疗法在一项小型早期试验中显示出治疗一种遗传性失明的前景,《新英格兰医学杂志》 。他们每人的一只眼睛都注射了一次Editas基因编辑疗法--EDIT-101。这项研究的主要目的是评估治疗的安全性。在治疗的第9周至第12周期间,接受胞二磷胆碱治疗的参与者中有32%成功戒烟,而接受安慰剂治疗的参与者中只有约15%戒烟。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432406505","title":"Achieve Life Sciences, Inc.盘中异动 股价大涨5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432406505","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432406505?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:31","pubTimestamp":1714573864,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时31分,Achieve Life Sciences, Inc.股票出现异动,股价快速上涨5.92%。Achieve Life Sciences, Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Achieve Life Sciences, Inc.公司简介:Achieve Life Sciences Inc 是一家专业制药公司,致力于推进金雀花碱作为广泛使用的治疗选择,帮助人们对抗尼古丁成瘾。Achieve 的重点是通过金雀花碱的开发和商业化来解决全球吸烟健康流行病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012231057925a237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012231057925a237&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428292344","title":"Achieve Life Sciences(ACHV.US)获JonesTrading首次覆盖,给予买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428292344","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428292344?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:25","pubTimestamp":1713363930,"startTime":"0","endTime":"0","summary":"Achieve Life Sciences(ACHV.US)获JonesTrading首次覆盖,给予买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172225348b3066d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172225348b3066d9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428360590","title":"美国研究综述-3M、J&J、Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2428360590","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428360590?lang=zh_cn&edition=full","pubTime":"2024-04-17 15:48","pubTimestamp":1713340130,"startTime":"0","endTime":"0","summary":" 路透社4月17日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价,其中包括 3M、J&J 和 Nuvalent。要闻 * 3M公司 :摩根大通将目标价从118美元下调至110美元 * J&J :加拿大皇家银行将目标价从181美元下调至175美元 * Nuvalent Inc :Jefferies给予买入评级,目标价97美元 * Tractor Supply Co :巴克莱将目标价从192美元上调至234美元 * UnitedHealth Group Inc :Piper Sandler将目标价从566美元上调至571美元 以下是路透社周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.achievelifesciences.com","stockEarnings":[{"period":"1week","weight":0.0592},{"period":"1month","weight":0.153},{"period":"3month","weight":0.1412},{"period":"6month","weight":-0.0253},{"period":"1year","weight":-0.361},{"period":"ytd","weight":0.216}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0244},{"period":"3month","weight":0.0496},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.267},{"period":"ytd","weight":0.101}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Achieve Life Sciences, Inc.成立于1991年10月,OncoGenex技术成立于2000年5月。 公司是一家临床阶段的制药公司,致力于全球的金雀花碱的戒烟开发和商业化。 他们的重点是解决全球吸烟健康流行。 Cytisine是已建立的为期25天的戒烟治疗,已在中东欧地区由Sopharma AD在商标名称TabexTM下批准并销售了20多年。 据估计,超过2000万人使用金雀花碱来帮助治疗尼古丁成瘾,其中包括2000多名在欧洲和新西兰进行的研究者进行的3期临床试验的患者。 这两项试验分别于2011年9月和2014年12月在新英格兰医学杂志上发表。","yearOnYearQuotes":[{"month":1,"riseRate":0.689655,"avgChangeRate":0.187078},{"month":2,"riseRate":0.517241,"avgChangeRate":0.015422},{"month":3,"riseRate":0.482759,"avgChangeRate":-0.022828},{"month":4,"riseRate":0.448276,"avgChangeRate":0.066693},{"month":5,"riseRate":0.448276,"avgChangeRate":0.214188},{"month":6,"riseRate":0.357143,"avgChangeRate":-0.062826},{"month":7,"riseRate":0.571429,"avgChangeRate":0.063576},{"month":8,"riseRate":0.321429,"avgChangeRate":-0.089695},{"month":9,"riseRate":0.357143,"avgChangeRate":-0.11774},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.098626},{"month":11,"riseRate":0.724138,"avgChangeRate":0.086212},{"month":12,"riseRate":0.482759,"avgChangeRate":-0.040526}],"exchange":"NASDAQ","name":"Achieve Life Sciences, Inc.","nameEN":"Achieve Life Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Achieve Life Sciences, Inc.(ACHV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Achieve Life Sciences, Inc.(ACHV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Achieve Life Sciences, Inc.,ACHV,Achieve Life Sciences, Inc.股票,Achieve Life Sciences, Inc.股票老虎,Achieve Life Sciences, Inc.股票老虎国际,Achieve Life Sciences, Inc.行情,Achieve Life Sciences, Inc.股票行情,Achieve Life Sciences, Inc.股价,Achieve Life Sciences, Inc.股市,Achieve Life Sciences, Inc.股票价格,Achieve Life Sciences, Inc.股票交易,Achieve Life Sciences, Inc.股票购买,Achieve Life Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Achieve Life Sciences, Inc.(ACHV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Achieve Life Sciences, Inc.(ACHV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}